What is Bluejay Diagnostics Inc (BJDX) stock price today?

Bluejay Diagnostics Inc (BJDX) currently trades at $1.88 per share. The stock has a market capitalization of $1.96M and a P/E ratio of —x.

Is BJDX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Bluejay Diagnostics Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -6.24.

Is Bluejay Diagnostics Inc financially healthy?

Bluejay Diagnostics Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -6.24 places it in the distress.

BJDX

Bluejay Diagnostics Inc

NASDAQ: BJDX · HEALTHCARE · MEDICAL DEVICES

$1.88

+4.44% today

Updated 2026-04-30

Market cap

$1.96M

P/E ratio

—

P/S ratio

54.99x

EPS (TTM)

$-15.25

Dividend yield

—

52W range

$2 – $17

Volume

0.2M

Market cap

$1.96M

P/E ratio

—

P/S ratio

54.99x

EPS (TTM)

$-15.25

Dividend yield

—

52W range

$2 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-6.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$256.00

+13517.02%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.04x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -6.24 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.63M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$249040.00	$0.00	$0.00	$0.00	$0.00
Net income	$-9.30M	$-9.95M	$-7.72M	$-6.85M	$-1.43M
EPS	—	—	—	—	$-15.25
Free cash flow	$-8.94M	$-9.02M	$-8.13M	$-6.23M	$-1.63M
Profit margin	-3,733.11%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BJDX	$1.96M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Bluejay Diagnostics Inc trades at $1.88. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -6.24, it sits in the distress.

Frequently asked questions

What is Bluejay Diagnostics Inc's stock price?

Bluejay Diagnostics Inc (BJDX) trades at $1.88.

Is Bluejay Diagnostics Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Bluejay Diagnostics Inc (BJDX)?

The analyst target price is $256.00, representing +13517.0% upside from the current price of $1.88.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-6.24 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

bluejaydx.com

Quick metrics

P/S ratio54.99x

ROE-117.00%

Beta0.67

50D MA$2.00

200D MA$4.75

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BJDX vs LLY →BJDX vs JNJ →BJDX vs ABBV →Stock screener →